{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:43:21Z","timestamp":1791924201834,"version":"4.3.4"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.2215\/cjn.06290615","type":"journal-article","created":{"date-parts":[[2016,1,4]],"date-time":"2016-01-04T20:48:43Z","timestamp":1451940523000},"page":"431-441","source":"Crossref","is-referenced-by-count":60,"title":["Trends in Survival and Renal Recovery in Patients with Multiple Myeloma or Light-Chain Amyloidosis on Chronic Dialysis"],"prefix":"10.2215","volume":"11","author":[{"given":"Alexandre","family":"Decourt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Gondouin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Christophe","family":"Delaroziere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Brunet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Sall\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephane","family":"Burtey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Dussol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vadim","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Couchoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemie","family":"Jourde-Chiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-11-20230601","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2141.2004.05207.x","article-title":"A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK.","volume":"127","author":"Phekoo","year":"2004","journal-title":"Br J Haematol"},{"key":"R2-11-20230601","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJM198402163100703","article-title":"Comparison of trends in the incidence of multiple myeloma in Malm\u00f6, Sweden, and other countries, 1950\u20131979.","volume":"310","author":"Turesson","year":"1984","journal-title":"N Engl J Med"},{"key":"R3-11-20230601","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1093\/ndt\/gfp679","article-title":"Incidence and outcome of patients starting renal replacement therapy for end-stage renal disease due to multiple myeloma or light-chain deposit disease: An ERA-EDTA Registry study.","volume":"25","author":"Tsakiris","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R4-11-20230601","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1093\/ndt\/gfp488","article-title":"Presentation and survival of patients with severe acute kidney injury and multiple myeloma: A 20-year experience from a single centre.","volume":"25","author":"Haynes","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R5-11-20230601","first-page":"207","article-title":"Multiple myeloma and light chain-associated nephropathy at end-stage renal disease in the United States: Patient characteristics and survival.","volume":"56","author":"Abbott","year":"2001","journal-title":"Clin Nephrol"},{"key":"R6-11-20230601","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1056\/NEJMoa043445","article-title":"Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.","volume":"352","author":"Richardson","year":"2005","journal-title":"N Engl J Med"},{"key":"R7-11-20230601","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1182\/blood-2007-10-116129","article-title":"Improved survival in multiple myeloma and the impact of novel therapies.","volume":"111","author":"Kumar","year":"2008","journal-title":"Blood"},{"key":"R9-11-20230601","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/bjh.12286","article-title":"Systemic amyloidosis in England: An epidemiological study.","volume":"161","author":"Pinney","year":"2013","journal-title":"Br J Haematol"},{"key":"R10-11-20230601","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1200\/JCO.2010.30.5235","article-title":"Outcome in renal AL amyloidosis after chemotherapy.","volume":"29","author":"Pinney","year":"2011","journal-title":"J Clin Oncol"},{"key":"R11-11-20230601","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.2215\/CJN.01730506","article-title":"Immunoglobulin light (heavy)-chain deposition disease: From molecular medicine to pathophysiology-driven therapy.","volume":"1","author":"Ronco","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"R12-11-20230601","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0002-9343(76)90440-X","article-title":"Manifestations of systemic light chain deposition.","volume":"60","author":"Randall","year":"1976","journal-title":"Am J Med"},{"key":"R13-11-20230601","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/ndt\/gfq022","article-title":"Disease classification: A pitfall of the ERA\/EDTA registry?","volume":"25","author":"Ronco","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"R14-11-20230601","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1053\/j.ajkd.2003.08.040","article-title":"Light chain deposition disease with renal involvement: Clinical characteristics and prognostic factors.","volume":"42","author":"Pozzi","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R15-11-20230601","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1093\/ndt\/gfi198","article-title":"The renal epidemiology and information network (REIN): A new registry for end-stage renal disease in France.","volume":"21","author":"Couchoud","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R16-11-20230601","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/ndt\/gfs492","article-title":"End-stage renal failure due to amyloidosis: Outcomes in 490 ANZDATA registry cases.","volume":"28","author":"Tang","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R17-11-20230601","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2215\/CJN.02470607","article-title":"Presentation and outcome of patients with systemic amyloidosis undergoing dialysis.","volume":"3","author":"Boll\u00e9e","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"R18-11-20230601","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1093\/ndt\/gfm684","article-title":"Renal involvement in systemic amyloidosis: An Italian collaborative study on survival and renal outcome.","volume":"23","author":"Bergesio","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"R19-11-20230601","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1001\/archinte.1992.00400230061010","article-title":"Dialysis support of patients with primary systemic amyloidosis: A study of 211 patients.","volume":"152","author":"Gertz","year":"1992","journal-title":"Arch Intern Med"},{"key":"R20-11-20230601","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/ndt\/gfp201","article-title":"Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney.","volume":"24","author":"Gertz","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R22-11-20230601","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1093\/ndt\/gfn698","article-title":"A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease.","volume":"24","author":"Couchoud","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"R23-11-20230601","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1093\/qjmed\/hcu043","article-title":"Survival of patients with ANCA-associated vasculitis on chronic dialysis: Data from the French REIN registry from 2002 to 2011.","volume":"107","author":"Romeu","year":"2014","journal-title":"QJM"},{"key":"R24-11-20230601","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1046\/j.1523-1755.2003.00803.x","article-title":"Reverse epidemiology of cardiovascular risk factors in maintenance dialysis patients.","volume":"63","author":"Kalantar-Zadeh","year":"2003","journal-title":"Kidney Int"},{"key":"R25-11-20230601","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1056\/NEJMoa030288","article-title":"A phase 2 study of bortezomib in relapsed, refractory myeloma.","volume":"348","author":"Richardson","year":"2003","journal-title":"N Engl J Med"},{"key":"R26-11-20230601","doi-asserted-by":"crossref","first-page":"2604","DOI":"10.1182\/blood-2006-09-046409","article-title":"Activity and safety of bortezomib in multiple myeloma patients with advanced renal failure: A multicenter retrospective study.","volume":"109","author":"Chanan-Khan","year":"2007","journal-title":"Blood"},{"key":"R27-11-20230601","doi-asserted-by":"crossref","first-page":"546","DOI":"10.3324\/haematol.10759","article-title":"Reversibility of renal failure in newly diagnosed multiple myeloma patients treated with high dose dexamethasone-containing regimens and the impact of novel agents.","volume":"92","author":"Kastritis","year":"2007","journal-title":"Haematologica"},{"key":"R28-11-20230601","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1600-0609.2009.01385.x","article-title":"Safety and efficacy of bortezomib-based regimens for multiple myeloma patients with renal impairment: A retrospective study of Italian Myeloma Network GIMEMA.","volume":"84","author":"Morabito","year":"2010","journal-title":"Eur J Haematol"},{"key":"R29-11-20230601","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/j.1600-6143.2012.04326.x","article-title":"Renal transplantation in systemic amyloidosis\u2014importance of amyloid fibril type and precursor protein abundance.","volume":"13","author":"Pinney","year":"2013","journal-title":"Am J Transplant"},{"key":"R30-11-20230601","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/ndt\/13.6.1438","article-title":"Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.","volume":"13","author":"Montseny","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"R31-11-20230601","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.2215\/CJN.12231212","article-title":"Kidney disease and multiple myeloma.","volume":"8","author":"Heher","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"R32-11-20230601","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1053\/j.ajkd.2003.09.020","article-title":"Long-term outcome of renal transplantation in light-chain deposition disease.","volume":"43","author":"Leung","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"R33-11-20230601","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/ndt\/gfq290","article-title":"Disease classification: A pitfall of the ERA\/EDTA registry?","volume":"25","author":"Tsakiris","year":"2010","journal-title":"Nephrol Dial Transplant"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201603000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:46:03Z","timestamp":1786369563000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201603000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.06290615","relation":{},"ISSN":["1555-9041"],"issn-type":[{"value":"1555-9041","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}